About CiMaas

About company

CiMaas develops therapies engaging the immune system for the treatment of a growing population facing cancer that cannot be cured by the current standard of care. A better cure relates to safe technology taking away several of the severe side-effects of current therapies. By doing so, the company will create quality value for patients and share holders.